APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 12 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,284,573 | -57.8% | 1,017,000 | -19.7% | 0.04% | -55.6% |
| Q2 2023 | $3,044,070 | +9.6% | 1,267,000 | -15.1% | 0.08% | +8.0% |
| Q1 2023 | $2,776,731 | +11.6% | 1,492,000 | -7.7% | 0.08% | +11.9% |
| Q4 2022 | $2,488,159 | +9.5% | 1,617,000 | +38.6% | 0.07% | +4.7% |
| Q3 2022 | $2,273,000 | +49.8% | 1,167,000 | +14.7% | 0.06% | +56.1% |
| Q2 2022 | $1,517,000 | -5.6% | 1,017,000 | 0.0% | 0.04% | +10.8% |
| Q1 2022 | $1,607,000 | +4.6% | 1,017,000 | 0.0% | 0.04% | +19.4% |
| Q4 2021 | $1,537,000 | -75.1% | 1,017,000 | -69.2% | 0.03% | -77.7% |
| Q2 2021 | $6,173,000 | +84.6% | 3,306,000 | +39.5% | 0.14% | +75.9% |
| Q1 2021 | $3,344,000 | -16.0% | 2,370,000 | 0.0% | 0.08% | -22.5% |
| Q4 2020 | $3,983,000 | +55.5% | 2,370,000 | 0.0% | 0.10% | +34.2% |
| Q3 2020 | $2,561,000 | – | 2,370,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |